Sagent Pharmaceuticals
Private Company
Total funding raised: $200M
Overview
Sagent Pharmaceuticals, founded in 2006 and headquartered in Schaumburg, Illinois, is a commercial-stage company focused on generic injectable pharmaceuticals. It leverages a global supply network to provide a diverse portfolio of small molecule drugs, with a strong emphasis on packaging innovation to reduce medication errors. The company operates as a private entity, serving the needs of healthcare providers and patients across the United States with a customer-centric business model.
Technology Platform
Proprietary PreventIV Measures® Packaging and Labeling system designed to reduce medication errors, combined with expertise in manufacturing sterile injectables (vials, premix bags, prefilled syringes).
Funding History
4Opportunities
Risk Factors
Competitive Landscape
Sagent competes with large diversified generic companies (e.g., Pfizer/Hospira, Fresenius Kabi, Hikma) and other pure-play injectable specialists. Competition is based on price, portfolio breadth, supply reliability, and packaging. Sagent's PreventIV Measures® system is a noted point of differentiation in a crowded field.